← Back to home

FDA Clears Novartis Drug Cosentyx for Polymyalgia Rheumatica

Fact checked by NewsPlainVerified by NewsPlain: confirmed by at least two named sources

Brief

The Food and Drug Administration cleared Novartis's Cosentyx for adults with polymyalgia rheumatica, the company announced on…

Keep reading with NewsPlain Premium

Get the full brief, the full story, what's confirmed, what's still unclear, why it matters, and every source.

5 confirmed facts and 2 sources behind this story.

About this story

We haven’t published a correction to this story.

How NewsPlain works
← Back to home